文献速递消化与肝胆胰病理细胞病理与分子病理

新近分子定义的骨与软组织肿瘤诊断:何时重要?

Emerging Molecularly Defined Bone and Soft Tissue Diagnoses: When Do They Matter?
PubMed 文献 · Mod Pathol · 2026-02-26

该综述介绍了3种基于分子遗传学特征新近分类的间叶性肿瘤:SRF重排肌样肿瘤、浅表CD34阳性成纤维细胞肿瘤和激酶改变的梭形细胞肿瘤。文章强调识别这些肿瘤的重要性,因其模仿者常具有显著不同的预后和管理策略,并讨论了辅助检查及避免诊断陷阱的策略。

要点

  • SRF重排肌样肿瘤、浅表CD34阳性成纤维细胞肿瘤和激酶改变梭形细胞肿瘤是分子定义的新实体。
  • 这些肿瘤的模仿者预后和治疗差异大,准确诊断至关重要。
  • 分子检测在诊断困难时有助于指导临床管理。

核心结论

  • 识别这3种分子定义的间叶性肿瘤对避免误诊至关重要,因其模仿者预后和治疗策略显著不同。

研究设计与样本

  • 综述,基于美国与加拿大病理学会长课程内容,介绍3种新近分子分类的间叶性肿瘤。

主要发现

  • SRF重排肌样肿瘤(原细胞性肌纤维瘤)、浅表CD34阳性成纤维细胞肿瘤和激酶改变梭形细胞肿瘤具有独特的临床病理特征。
  • 这些肿瘤的模仿者常具有显著不同的预后和管理策略。

临床怎么用

  • 病理医生应熟悉这3种肿瘤的关键临床病理特征,必要时进行分子检测以指导诊断和临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With the rapid advancement of molecular pathology and the explosion of genomic data, our understanding of neoplasms continues to evolve. In this review, we introduce 3 recently classified mesenchymal neoplasms, the categorization of which was refined based on their underlying molecular genetic profiles. These entities were recently highlighted by the senior author at the United States and Canadian Academy of Pathology Long Course. To underscore the importance of their proper recognition, this review was prepared to reach a broader audience. Recognition of these tumors is particularly important because their mimickers often have markedly disparate prognoses and management strategies, making accurate diagnosis critical. The 3 entities discussed in this study are the following: (1) SRF-rearranged myoid neoplasms (formerly cellular myofibroma), (2) superficial CD34-positive fibroblastic tumors, and (3) kinase-altered spindle cell neoplasms. This review aimed to highlight the key clinicopathologic features of these tumors to facilitate accurate diagnosis, discuss ancillary studies that assist in navigating the differential diagnoses, and outline strategies to avoid common diagnostic pitfalls. Finally, we emphasize when molecular characterization may be necessary to guide diagnosis and support appropriate clinical management.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Davis JL, Samiei A. Emerging Molecularly Defined Bone and Soft Tissue Diagnoses: When Do They Matter? Mod Pathol. 2026. PMID: 41759784. doi:10.1016/j.modpat.2026.100981

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。